{"id":47469,"date":"2023-11-29T01:20:00","date_gmt":"2023-11-29T00:20:00","guid":{"rendered":"https:\/\/www.stille.se\/se\/mfn_news\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/"},"modified":"2026-08-10T13:01:20","modified_gmt":"2026-08-10T11:01:20","slug":"stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments","status":"publish","type":"mfn_news","link":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/","title":{"rendered":"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Stille AB (publ) (&#8220;Stille&#8221; eller &#8220;Bolaget&#8221;) har ing&aring;tt ett avtal om att f&ouml;rv&auml;rva samtliga utest&aring;ende aktier i Fehling Instruments GmbH &amp; Co. KG och Fehling Verwaltungs GmbH (tillsammans &#8220;Fehling&#8221;) f&ouml;r en k&ouml;peskilling om 36 MEUR (cirka 410 MSEK) p&aring; en kassa- och skuldfri basis. F&ouml;rv&auml;rvet &auml;r villkorat av att Bolaget erh&aring;ller tillr&auml;cklig finansiering f&ouml;r genomf&ouml;rande av f&ouml;rv&auml;rvet och Bolagets styrelse avser s&aring;ledes att fatta beslut om en riktad emission av aktier villkorat av bolagsst&auml;mmans efterf&ouml;ljande godk&auml;nnande. Genom f&ouml;rv&auml;rvet breddar Stille avsev&auml;rt sitt produktutbud, globala n&auml;rvaro och FoU-kapacitet. Fehling redovisade &aring;r 2022 en f&ouml;rs&auml;ljning om 15,8 MEUR och justerad EBITDA om cirka 4,8 MEUR. F&ouml;rv&auml;rvet av Fehling f&ouml;rv&auml;ntas slutf&ouml;ras i slutet januari 2024, f&ouml;rutsatt att alla villkor har uppfyllts.<\/strong><\/div>\n<h3><span>Bakgrund och f&ouml;rv&auml;rv av Fehling<\/span><\/h3>\n<h4><span>L&aring;ng historia av tillverkning av kirurgiska premiuminstrument<\/span><\/h4>\n<p class=\"mfn-wp-retain\"><span><span><span>Fehling &auml;r ett familje&auml;gt tyskt f&ouml;retag, grundat 1996, som utvecklar och s&auml;ljer medicinska instrument av h&ouml;g kvalitet. Fehling har en stark marknadsposition med direktverksamhet i Tyskland, Schweiz, USA, Singapore, F&ouml;renade Arabemiraten och Malaysia. Med &ouml;ver 30 &aring;rs branscherfarenhet str&auml;var Fehling efter att tillhandah&aring;lla ett brett utbud av premiumprodukter till kirurger med fokus p&aring; kr&auml;vande specialiteter som &ouml;ppen och minimalinvasiv hj&auml;rt-, thorax-, neuro- och ryggkirurgi. Fehling har en global f&ouml;rs&auml;ljningsn&auml;rvaro kombinerat av direktf&ouml;rs&auml;ljning och distribut&ouml;rer. F&ouml;rs&auml;ljningstillv&auml;xten uppgick under 2022 till 9 procent med en f&ouml;rs&auml;ljningsmix f&ouml;rdelat mellan traditionella instrument cirka 72 procent, mikroinstrument cirka 18 procent samt MICS cirka 10 procent.<\/span><sup>1<\/sup><\/span><\/span><\/p>\n<h4><span>Breddat produkterbjudande och st&auml;rkt position inom kirurgiska instrument<\/span><\/h4>\n<p class=\"mfn-wp-retain\"><span><span><span>F&ouml;rv&auml;rvet &auml;r i linje med Stilles strategiska m&aring;l f&ouml;r tillv&auml;xt och belyser m&ouml;jligheterna till konsolidering i den nischade och fragmenterade marknaden f&ouml;r premiumkirurgiska instrument. Genom f&ouml;rv&auml;rvet kommer Stille att avsev&auml;rt bredda sitt produktutbud. Genom Fehlings direkta f&ouml;rs&auml;ljningskanaler och befintliga distribut&ouml;rsrelationer kommer Stille ocks&aring; &ouml;ka sin globala n&auml;rvaro och ytterligare st&auml;rka sin position p&aring; strategiskt viktiga marknader.&nbsp;<\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span>&#8220;F&ouml;rv&auml;rvet av Fehling inneb&auml;r att vi st&auml;rker v&aring;rt erbjudande som den mest h&ouml;gkvalitativa tillverkaren av kirurgiska instrument i premiumsegmentet inom utvalda, nischade kliniska segment. Detta tillf&ouml;r ett betydande v&auml;rde till Stilles verksamhet. Stilles kirurgiska produkterbjudande kompletteras nu starkt och respektive f&ouml;retags distributionskanaler ger betydande m&ouml;jligheter till &ouml;kad f&ouml;rs&auml;ljning&rdquo;, kommenterar Torbj&ouml;rn Sk&ouml;ld, VD, Stille.<\/span><\/span><\/span><\/p>\n<h4><span>Det sammanslagna bolaget<sup>2<\/sup><\/span><\/h4>\n<p class=\"mfn-wp-retain\"><span><span><span>Det sammanslagna bolaget omsatte f&ouml;r r&auml;kenskaps&aring;ret 2022 cirka 426 (352) MSEK med justerad EBITDA om cirka 97 (65) MSEK. Koncernen kommer, efter f&ouml;rv&auml;rvet, att ha direktverksamhet i Sverige, Tyskland, Schweiz, USA, Singapore, F&ouml;renade Arabemiraten och Malaysia. Fehling kommer att bli en del av Stilles aff&auml;rsenhet Surgical Instruments. Efter f&ouml;rv&auml;rvet f&ouml;rv&auml;ntas Stilles vinst per aktie &ouml;ka avsev&auml;rt. Gerald Fehling, VD f&ouml;r Fehling, kommer att beh&aring;lla sin position och ing&aring; i Stilles ledningsgrupp.&nbsp;<\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span>&rdquo;Jag ser med tillf&ouml;rsikt fram emot att vara en del av Stilles organisation, integrera v&aring;ra verksamheter och realisera synergier&#8221; kommenterar Gerald Fehling, VD, Fehling.<\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span>&#8220;Vi har en tydlig strategi och tillv&auml;xtagenda inom Stille. Det &auml;r gl&auml;djande att vi nu har lyckats f&ouml;rv&auml;rva ytterligare en verksamhet som uppfyller v&aring;ra kriterier vad g&auml;ller fokus, l&ouml;nsamhet och tillv&auml;xtpotential. F&ouml;rv&auml;rvet &auml;r ett viktigt steg i Stilles p&aring;g&aring;ende resa mot att vara en ledande akt&ouml;r inom premiumsegmentet f&ouml;r kirurgiska instrument, s&auml;ger Lars Kvarnhem, styrelseordf&ouml;rande Stille.<\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><sup>1<\/sup>V&auml;nligen se bilagan med finansiell information om Fehling som utg&ouml;r en del av detta pressmeddelande.<\/span><\/span><br \/>\n<sup>2<\/sup><span>EUR\/SEK p&aring; 11,43.<\/span><\/p>\n<h3><span><span>Villkor f&ouml;r transaktionen och finansiering<\/span><\/span><\/h3>\n<p class=\"mfn-wp-retain\"><span><span><span><span>F&ouml;rv&auml;rvet &auml;r villkorat av att Bolaget erh&aring;ller tillr&auml;cklig finansiering f&ouml;r genomf&ouml;rande av f&ouml;rv&auml;rvet och Bolagets styrelse avser s&aring;ledes att fatta beslut om en riktad emission av aktier villkorat av bolagsst&auml;mmans efterf&ouml;ljande godk&auml;nnande. K&ouml;peskillingen f&ouml;r Fehling utg&ouml;r ett kontant- och skuldfritt v&auml;rde om 36 MEUR (cirka 410 MSEK) och avses att finansieras med kontanta medel fr&aring;n den riktade emissionen. Stille avser att genomf&ouml;ra en riktad nyemission till institutionella investerare med avvikelse fr&aring;n aktie&auml;garnas f&ouml;retr&auml;desr&auml;tt f&ouml;r att finansiera vederlaget. F&ouml;rv&auml;rvet av Fehling f&ouml;rv&auml;ntas slutf&ouml;ras i slutet januari 2024 f&ouml;rutsatt att ovan villkor &auml;r uppfyllt. Fehling kommer att konsolideras in i Stille vid slutf&ouml;randet av f&ouml;rv&auml;rvet.<\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span>Stille har utsett Pareto Securities (&rdquo;Pareto&rdquo;) till Sole Manager och Bookrunner i samband med den riktade emissionen av aktier till en utvald grupp investerare (dvs. en s.k. club deal), som kommer att offentligg&ouml;ras separat omedelbart efter publiceringen av detta pressmeddelande.<\/span><\/span><\/span><\/span><\/p>\n<h3><span><span>R&aring;dgivare<\/span><\/span><\/h3>\n<p class=\"mfn-wp-retain\"><span><span>Evli Corporate Finance AB har agerat finansiell r&aring;dgivare till Stille med anledning av f&ouml;rv&auml;rvet.<\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span>Torsh&auml;lla, Sverige, 29 november 2023<br \/>\nStille AB (publ)<\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span><strong>F&ouml;r ytterligare information, v&auml;nligen kontakta:<\/strong><br \/>\nTorbj&ouml;rn Sk&ouml;ld<br \/>\nVD och koncernchef<br \/>\n+46 (0)70 316 63 91 | torbjorn.skold@stille.se&nbsp;<\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><span><span><span>Niklas Carl&eacute;n<br \/>\nCFO<br \/>\n+46 (0)73 087 49 70 | niklas.carlen@stille.se&nbsp;<\/span><\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><span><em><span>Detta &auml;r information som Stille AB (publ) &auml;r skyldigt att offentligg&ouml;ra enligt EU:s marknadsmissbruksf&ouml;rordning. Informationen l&auml;mnades, genom ovanst&aring;ende kontaktpersoners f&ouml;rsorg, f&ouml;r offentligg&ouml;rande den 29 november 2023 kl. 01:20 CET.<\/span><\/em><\/span><\/p>\n<h4><span><span>Om Stille AB (publ)<\/span><\/span><\/h4>\n<p class=\"mfn-wp-retain\"><span><span><span>Stille AB (publ) utvecklar, tillverkar och marknadsf&ouml;r medicintekniska produkter f&ouml;r specialistkirurger v&auml;rlden &ouml;ver. Stille grundades 1841 och &auml;r ett av v&auml;rldens &auml;ldsta f&ouml;retag inom medicinteknik. Stilles prioriterade aff&auml;rsomr&aring;den &auml;r kirurgiska instrument och operationsbord. Stilles kirurgiska instrument anv&auml;nds framf&ouml;rallt vid olika typer av &ouml;ppen kirurgi. N&auml;r det g&auml;ller minimalinvasiva ingrepp &auml;r operationsborden imagiQ2 och Medstone nyckelprodukter. Bolaget har en stabil bas med ett starkt varum&auml;rke och v&auml;lk&auml;nda produkter av erk&auml;nt h&ouml;g kvalitet. Aktien &auml;r noterad p&aring; marknadsplatsen First North Growth Market under kortnamnet &rdquo;STIL&rdquo; med Eminova AB som Certified Adviser. Eminova Fondkommission AB + 46 8 684 211 10, adviser@eminova.se. F&ouml;r mer information, bes&ouml;k www.stille.se.<\/span><\/span><\/span><\/p>\n<h3><span><span>Bilaga<\/span><\/span><\/h3>\n<p class=\"mfn-wp-retain\"><span><span><span>Stille rapporterar enligt redovisningen IFRS och Fehling enligt tysk GAAP. F&ouml;ljande information utg&ouml;r en sammanslagning av respektive bolags redovisade finansiella information utan justeringar i skillnader mellan till&auml;mpade redovisningsstandarder. Konsoliderad finansiell information som rapporteras av Stille efter f&ouml;rv&auml;rvet genomf&ouml;rts kan komma att skilja sig v&auml;sentligt fr&aring;n den kombinerade finansiella information som &aring;terfinns h&auml;ri.<\/span><\/span><\/span><\/p>\n<p class=\"mfn-wp-retain\"><strong><span>Fehlings finansiella &ouml;versikt &ndash; Konsoliderat resultat f&ouml;r r&auml;kenskaps&aring;ren 2019-2022, H1 2023 och LTM (06\/2023)<\/span><\/strong><\/p>\n<p class=\"mfn-wp-retain\">\n<table>\n<tbody>\n<tr>\n<td nowrap><span><span><span><span><span><strong><span><span>(MEUR)<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2019<sup>2<\/sup><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2020<sup>2<\/sup><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2021<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2022<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>H1 2023<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>LTM (06\/2023)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Oms&auml;ttning<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>13,36<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>13,73<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>14,46<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>15,75<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>8,57<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>17,21<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Bruttoresultat<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>7,44<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>7,45<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>8,31<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>10,32<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>5,43<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>10,90<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><em>Marginal<\/em><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>55,7%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>54,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>57,5%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>65,5%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>63,4%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>63,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Operativa kostnader<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>(5,03)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>(4,95)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(5,10)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(5,65)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(2,80)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(5,75)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>EBITDA (justerad)<sup>1<\/sup><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>2,51<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>2,52<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>3,31<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>4,80<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2,69<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>5,27<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><em>EBITDA-marginal<\/em><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>18,8%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>18,4%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>22,9%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,5%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>31,4%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,6%<\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>EBIT (justerad)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>2,46<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>2,47<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>3,20<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>4,73<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2,66<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>5,20<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><em>EBIT-marginal<\/em><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>18,4%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>18,0%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>22,1%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,0%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>31,0%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,2%<\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Nettoresultat<sup>3<\/sup><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>&#8211;<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>&#8211;<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2,25<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>4,12<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>2,25<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>4,21<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"mfn-wp-retain\">\n<span><strong><span>Kombinerade resultatr&auml;kningar &ndash; Hel&aring;r 2021, Hel&aring;r 2022, och LTM (06\/2023)<\/span><\/strong><\/span><\/p>\n<p class=\"mfn-wp-retain\">\n<table>\n<tbody>\n<tr>\n<td nowrap><\/td>\n<td colspan=\"3\"><span><span><span><span><span><strong>Stille<sup>4<\/sup><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td colspan=\"3\"><span><span><span><span><span><strong>Fehling<sup>5,6<\/sup><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td colspan=\"3\"><span><span><span><span><span><strong>Kombinerat<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td><span><span><span><span><em><span>Reviderat<\/span><\/em><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><em><span>Reviderat<\/span><\/em><\/span><\/span><\/span><\/span><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong><span><span>(MSEK)<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>Hel&aring;r 2021<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>Hel&aring;r 2022<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>LTM (06\/2023)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>Hel&aring;r 2021<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>Hel&aring;r 2022<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>LTM (06\/2023)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>Hel&aring;r 2021<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>Hel&aring;r 2022<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>LTM (06\/2023)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Oms&auml;ttning<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>187,1<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>246,3<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>268,9<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>165,3<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>180,0<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>196,8<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>352,4<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>426,3<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>465,7<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Bruttoresultat<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>83,5<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>111,6<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>117,5<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>95,0<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>118,0<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>124,6<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>178,5<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>229,6<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>242,1<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><em>Marginal<\/em><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>44,6%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>45,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>43,7%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>57,5%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>65,5%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>63,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>50,7%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>53,9%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>52,0%<\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>Operativa kostnader<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>(63,4)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>(79,2)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(82,4)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(58,5)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(64,0)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(65,2)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(121,9)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(143,2)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>(147,6)<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>EBITDA<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>26,8<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>42,1<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>47,2<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>37,8<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>54,9<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>60,2<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>64,6<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>97,0<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>107,4<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><em>EBITDA-marginal<\/em><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>14,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>17,1%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>17,6%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>22,9%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,5%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,6%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>18,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>22,7%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>23,1%<\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td nowrap><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><strong>EBIT<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>20,1<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span><strong>32,4<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>35,1<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>36,5<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>54,0<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>59,4<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>56,6<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>86,4<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span><strong>94,5<\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<tr>\n<td nowrap><span><span><span><span><span><em>EBIT-marginal<\/em><\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>10,7%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td nowrap><span><span><span><span><span>13,2%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>13,1%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>22,1%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,0%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>30,2%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>16,1%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>20,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<td><span><span><span><span><span>20,3%<\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"mfn-wp-retain\"><span><span>Not 1) Justerat f&ouml;r poster av eng&aring;ngskarakt&auml;r.<br \/>\nNot 2) Finansiell information f&ouml;r 2019 och 2020 var inte en del av den finansiella due diligence, faktiska siffror kan variera.<br \/>\nNot 3) D&aring; bolagsstrukturen inom Fehling-koncernen inneh&aring;ller ett kommanditbolag, d&auml;r kommanditbolagets &auml;gare erl&auml;gger skatt, s&aring; &auml;r historiska nettotresultatet inte n&ouml;dv&auml;ndigtvis representativt eftersom resultaten fram&ouml;ver kommer p&aring;verkas av en annan skattesats n&auml;r Fehling integreras med Stille.<br \/>\nNot 4) Reviderade finansiella rapporter.&nbsp;<br \/>\nNot 5) Fehlings f&ouml;renklade resultatr&auml;kning.<br \/>\nNot 6) EUR\/SEK p&aring; 11,43<\/span><\/span><\/p>\n<div class=\"mfn-footer\"><\/div>\n<div class=\"mfn-footer mfn-about\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-file-type-pdf mfn-primary\"><a class=\"mfn-attachment-link\" target=\"_blank\" href=\"https:\/\/storage.mfn.se\/proxy\/pressmeddelande-stille-forvarvar-fehling-instruments.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F1000%2F3884097%2F2461641.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/pressmeddelande-stille-forvarvar-fehling-instruments.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F1000%2F3884097%2F2461641.pdf&type=jpg\"><\/span>Pressmeddelande - Stille fo\u0308rva\u0308rvar Fehling Instruments<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Stille AB (publ) (&#8220;Stille&#8221; eller &#8220;Bolaget&#8221;) har ing&aring;tt ett avtal om att f&ouml;rv&auml;rva samtliga utest&aring;ende aktier i Fehling Instruments GmbH &amp; Co. KG och Fehling Verwaltungs GmbH (tillsammans &#8220;Fehling&#8221;) f&ouml;r en k&ouml;peskilling om 36 MEUR (cirka 410 MSEK) p&aring; en kassa- och skuldfri basis. F&ouml;rv&auml;rvet &auml;r villkorat av att Bolaget erh&aring;ller tillr&auml;cklig finansiering f&ouml;r genomf&ouml;rande&#8230;<\/p>\n","protected":false},"template":"","mfn-news-tag":[1254,1227,1234,1226,1258,1233,1229],"class_list":["post-47469","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-lang-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments - STILLE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments - STILLE\" \/>\n<meta property=\"og:description\" content=\"Stille AB (publ) (&#8220;Stille&#8221; eller &#8220;Bolaget&#8221;) har ing&aring;tt ett avtal om att f&ouml;rv&auml;rva samtliga utest&aring;ende aktier i Fehling Instruments GmbH &amp; Co. KG och Fehling Verwaltungs GmbH (tillsammans &#8220;Fehling&#8221;) f&ouml;r en k&ouml;peskilling om 36 MEUR (cirka 410 MSEK) p&aring; en kassa- och skuldfri basis. F&ouml;rv&auml;rvet &auml;r villkorat av att Bolaget erh&aring;ller tillr&auml;cklig finansiering f&ouml;r genomf&ouml;rande...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/\" \/>\n<meta property=\"og:site_name\" content=\"Stille SE\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/stilleab\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-10T11:01:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stille.se\/app\/uploads\/2019\/12\/stille-logo-800.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"562\" \/>\n\t<meta property=\"og:image:height\" content=\"314\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/nyheter\\\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\\\/\",\"url\":\"https:\\\/\\\/www.stille.se\\\/se\\\/nyheter\\\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\\\/\",\"name\":\"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments - STILLE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/#website\"},\"datePublished\":\"2023-11-29T00:20:00+00:00\",\"dateModified\":\"2026-08-10T11:01:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/nyheter\\\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.stille.se\\\/se\\\/nyheter\\\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/nyheter\\\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/www.stille.se\\\/se\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nyheter\",\"item\":\"https:\\\/\\\/www.stille.se\\\/se\\\/nyheter\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/#website\",\"url\":\"https:\\\/\\\/www.stille.se\\\/se\\\/\",\"name\":\"Stille SE\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.stille.se\\\/se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/#organization\",\"name\":\"Stille AB\",\"url\":\"https:\\\/\\\/www.stille.se\\\/se\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Stille AB\"},\"image\":{\"@id\":\"https:\\\/\\\/www.stille.se\\\/se\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/stilleab\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/stille-ab\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCpxmVroiwKKSXWe3ZCOrSqw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments - STILLE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/","og_locale":"sv_SE","og_type":"article","og_title":"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments - STILLE","og_description":"Stille AB (publ) (&#8220;Stille&#8221; eller &#8220;Bolaget&#8221;) har ing&aring;tt ett avtal om att f&ouml;rv&auml;rva samtliga utest&aring;ende aktier i Fehling Instruments GmbH &amp; Co. KG och Fehling Verwaltungs GmbH (tillsammans &#8220;Fehling&#8221;) f&ouml;r en k&ouml;peskilling om 36 MEUR (cirka 410 MSEK) p&aring; en kassa- och skuldfri basis. F&ouml;rv&auml;rvet &auml;r villkorat av att Bolaget erh&aring;ller tillr&auml;cklig finansiering f&ouml;r genomf&ouml;rande...","og_url":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/","og_site_name":"Stille SE","article_publisher":"https:\/\/www.facebook.com\/stilleab\/","article_modified_time":"2026-08-10T11:01:20+00:00","og_image":[{"width":562,"height":314,"url":"https:\/\/www.stille.se\/app\/uploads\/2019\/12\/stille-logo-800.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/","url":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/","name":"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments - STILLE","isPartOf":{"@id":"https:\/\/www.stille.se\/se\/#website"},"datePublished":"2023-11-29T00:20:00+00:00","dateModified":"2026-08-10T11:01:20+00:00","breadcrumb":{"@id":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stille.se\/se\/nyheter\/stille-har-ingatt-avtal-om-att-forvarva-fehling-instruments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/www.stille.se\/se\/"},{"@type":"ListItem","position":2,"name":"Nyheter","item":"https:\/\/www.stille.se\/se\/nyheter\/"},{"@type":"ListItem","position":3,"name":"Stille har ing\u00e5tt avtal om att f\u00f6rv\u00e4rva Fehling Instruments"}]},{"@type":"WebSite","@id":"https:\/\/www.stille.se\/se\/#website","url":"https:\/\/www.stille.se\/se\/","name":"Stille SE","description":"","publisher":{"@id":"https:\/\/www.stille.se\/se\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stille.se\/se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/www.stille.se\/se\/#organization","name":"Stille AB","url":"https:\/\/www.stille.se\/se\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/www.stille.se\/se\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Stille AB"},"image":{"@id":"https:\/\/www.stille.se\/se\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/stilleab\/","https:\/\/www.linkedin.com\/company\/stille-ab\/","https:\/\/www.youtube.com\/channel\/UCpxmVroiwKKSXWe3ZCOrSqw"]}]}},"_links":{"self":[{"href":"https:\/\/www.stille.se\/se\/wp-json\/wp\/v2\/mfn_news\/47469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stille.se\/se\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.stille.se\/se\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.stille.se\/se\/wp-json\/wp\/v2\/media?parent=47469"}],"wp:term":[{"taxonomy":"mfn-news-tag","embeddable":true,"href":"https:\/\/www.stille.se\/se\/wp-json\/wp\/v2\/mfn-news-tag?post=47469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}